Abstract
This article describes the use of a topical glycerine hydrogel and the role it can play in the management of malignant fungating wounds. The value of the product is reviewed in two case studies. The authors accept that no significant statistical evidence can be offered from the case studies, but highlight the benefit of the product to the patients' quality of life.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
